Pomelo Care’s Virtual Maternity Program Shows Dose-Response Gains in Outcomes and Cost Savings

New updates have been reported about Pomelo Care.

Pomelo Care has released peer-reviewed outcomes data indicating that its technology-enabled virtual maternity program produces a clear dose-response effect on clinical results and costs for payers. In a flagship study using administrative claims from nearly 45,000 deliveries across six health plans and six states, longer prenatal engagement with Pomelo was linked to progressively lower preterm birth rates, reduced neonatal intensive care unit (NICU) utilization, and direct savings for health plans and employers.

Patients who used Pomelo’s program for at least three months before delivery saw a 24.4% reduction in preterm births and more than a 26% reduction in NICU length of stay compared with similar populations, with benefits starting in the first month and increasing over time. This pattern supports the view that Pomelo’s integrated model—fully employed clinicians supported by proprietary technology, real-time health information exchange data, and remote monitoring—drives the improvement rather than patient selection bias.

Because the analysis relies on administrative claims rather than self-reported data or app engagement metrics, the observed drop in NICU use and associated services translates into measurable near-term cost savings for payers. The company’s approach targets evolving clinical risk throughout pregnancy, closing care gaps related to conditions such as gestational hypertension, gestational diabetes, and perinatal mood disorders before they escalate into higher-cost events.

A second study focused on first-time mothers with no prior claims history, a cohort often considered low risk by traditional payer analytics. Pomelo’s analysis showed that these patients actually had a 42% higher probability of developing hypertensive disorders of pregnancy than members with established claims histories, even after controlling for demographics, highlighting the limitations of historical claims as a sole risk stratification tool.

By continuously integrating multiple data sources and surfacing early clinical signals to its clinicians, Pomelo positions itself as a partner for payers and employers seeking demonstrable return on investment from digital maternity solutions. Chief executive Marta Bralic Kerns emphasized that outcomes improved as families engaged longer with the program, underscoring the value of sustained virtual clinical management rather than one-time digital interactions.

The findings, developed with the Leonard Davis Institute of Health Economics at the University of Pennsylvania and presented at the Society for Maternal-Fetal Medicine 2026 Pregnancy Meeting, provide external validation that Pomelo’s care model can scale while maintaining impact on both outcomes and cost. For health plans, employers, and provider partners, the research signals that virtual maternity care, when tightly integrated with clinical teams and claims-based measurement, can play a material role in reducing preterm births, NICU burden, and overall maternity spend.